Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed4
Recruiting1
Other3

Role Distribution

Principal Investigator8
PI Rate100%

Activity Timeline

Clinical Trials (8)

NCT05148572Active Not Recruiting
Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular Carcinoma
Hepatocellular Carcinoma
PrincipalinvestigatorStart date: 2021-11-10
NCT04965259Active Not Recruiting
Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)
Liver Diseases
PrincipalinvestigatorStart date: 2021-04-15
NCT06294808Completed
Predicting Survival After Surgical Resection for the Entire Spectrum of Anatomically Resectable HCC
Hepatocellular Carcinoma Resectable
PrincipalinvestigatorStart date: 2017-07-17
NCT03233360Completed
Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry
Hepatocellular Carcinoma
PrincipalinvestigatorStart date: 2017-04-17
NCT03267641Completed
Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma
Hepatocellular Carcinoma
PrincipalinvestigatorStart date: 2016-05-16

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT05516628Phase 2PrincipalInvestigator

Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma

Hepatocellular Carcinoma
Recruiting
NCT05377034Phase 2PrincipalInvestigator

Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients

Locally Advanced Hepatocellular Carcinoma
Active Not Recruiting
NCT05148572PrincipalInvestigator

Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular Carcinoma

Hepatocellular Carcinoma
Active Not Recruiting
NCT04965259PrincipalInvestigator

Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)

Liver Diseases
Active Not Recruiting
NCT04961489PrincipalInvestigator

Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes

Surgery
Completed
NCT06294808PrincipalInvestigator

Predicting Survival After Surgical Resection for the Entire Spectrum of Anatomically Resectable HCC

Hepatocellular Carcinoma Resectable
Completed
NCT03233360PrincipalInvestigator

Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry

Hepatocellular Carcinoma
Completed
NCT03267641PrincipalInvestigator

Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma

Hepatocellular Carcinoma
Completed

All 8 trials loaded